Pneumococcal conjugate second or third-dose vaccines (PCVc) in Malaysia
Malaysia: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 93.0% in 2025. ◆ Volatile
Latest (2025)
93.0%
Change on year
up 3.3%
World rank
53rd
of 194 countries
All-time high
95.0%
in 2023
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Malaysia, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Malaysia recorded 93.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) in 2025.
Compared with earlier readings it is up 3.3% on the previous year.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Malaysia peaked at 95.0% in 2023 and was at its lowest, 0.0%, in 2008.
Malaysia ranks 53rd of 194 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Malaysia, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 0.0% | — |
| 2016 | 0.0% | — |
| 2017 | 0.0% | — |
| 2018 | 0.0% | — |
| 2019 | 0.0% | — |
| 2020 | 0.0% | — |
| 2021 | 76.0% | — |
| 2022 | 86.0% | +13.2% |
| 2023 | 95.0% | +10.5% |
| 2024 | 90.0% | -5.3% |
| 2025 | 93.0% | +3.3% |
Malaysia compared with similar countries
- Malaysia's 93.0% is above the median for upper middle income countries, which is 76.0%, 1.2× the median. (57 countries reporting)
- Malaysia's 93.0% is above the median for East Asia & Pacific, which is 81.0%, 1.1× the median. (30 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 0.0% | 0.0% | 0.0% | 10 |
| 2020s | 73.3% | 0.0% | 95.0% | 6 |
Countries ranked near Malaysia
More health data for Malaysia
- Un projection of annual infant deaths, annual growth rate -0.9119 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.2888 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,250 deaths per 1,000 people (2090)
- Number of infants who die before age 1 652 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 18 (2025)
- Population ages 00-04, female, annual growth rate -0.7207 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0297 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5991 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Malaysia?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Malaysia was 93.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Malaysia?
- The highest recorded value was 95.0% in 2023.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Malaysia?
- The lowest recorded value was 0.0% in 2008.
- How does Malaysia rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Malaysia ranks 53rd out of 194 countries with data for 2025.
- Where does this Malaysia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).